Diksha Diksha

Ms. Diksha Diksha

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JMJogender Mehla
Jogender Mehla
PGPooja Gupta
Pooja Gupta
MPMonika Pahuja
Monika Pahuja
DDDeepti Diwan
Deepti Diwan
Diksha DikshaDiksha Diksha
Diksha Diksha
Cognitive impairment, associated with ageing, stress, hypertension and various neurodegenerative disorders including Parkinson’s disease and epilepsy, is a major health issue. The present review focuses on Alzheimer’s disease (AD), since it is the most important cause of cognitive impairment. It is characterized by progressive memory loss, language deficits, depression, agitation, mood disturbances and psychosis. Although the hallmarks of AD are cholinergic dysfunction, β-amyloid plaques and neurofibrillary tangle formation, it is also associated with derangement of other neurotransmitters, elevated levels of advanced glycation end products, oxidative damage, neuroinflammation, genetic and environmental factors. On one hand, this complex etiopathology makes a response to commonly used drugs such as donepezil, rivastigmine, galantamine and memantine less predictable and often unsatisfactory. On the other hand, it supports the use of herbal medicines due to their nonspecific antioxidant and anti-inflammatory activity and specific cholinesterase inhibitory activity. The popularity of herbal medicines is also increasing due to their perceived effectiveness, safety and affordability. In the present article, the experimental and clinical evidence have been reviewed for various Indian herbal medicines such as Centella asiatica, Bacopa monnieri, Curcuma longa, Clitoria ternatea, Withania somnifera, Celastrus paniculatus, Evolvulus alsinoides, Desmodium gangeticum, Eclipta alba, Moringa oleifera and Convolvulus pluricaulis, which have shown potential in cognitive impairment. Some commonly available herbal formulations for memory impairment in India have also been reviewed.

23 September 2019 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
Diksha DikshaDiksha Diksha
Diksha Diksha
PGPooja Gupta
Pooja Gupta
PMPrabhat Malik
Prabhat Malik
AMAnant Mohan
Anant Mohan

5 September 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
RDRekha Dwivedi
Rekha Dwivedi
RGRashmi Gupta
Rashmi Gupta
JPJasmine Parihar
Jasmine Parihar
Diksha DikshaDiksha Diksha
Diksha Diksha
AUASHISH DATT UPADHYAY
ASHISH DATT UPADHYAY
PTPrabhakar Tiwari
Prabhakar Tiwari
Neuroinflammation is increasingly recognized as a critical contributor to epileptogenesis and pharmacoresistance in temporal lobe epilepsy (TLE). MicroRNAs (miRNAs) are key post-transcriptional regulators of immune signaling, neuronal excitability, and inflammatory responses; however, their contribution to treatment resistance remains incompletely understood. This study aimed to characterize peripheral neuroinflammatory miRNA signatures associated with pharmacoresistance in TLE and evaluate their discriminatory performance and correlation-based co-expression patterns. In this cross-sectional study, 80 patients with TLE were stratified into responders (n = 40) and non-responders (n = 40) according to International League Against Epilepsy criteria for treatment response. Expression levels of ten candidate miRNAs implicated in neuroinflammation, neuronal homeostasis, and apoptosis were quantified in peripheral blood mononuclear cells (PBMC) using RT-qPCR. Differential expression, receiver operating characteristic (ROC), and correlation-based network analyses were performed. Responders exhibited significantly higher expression of miR-146a, miR-132, miR-139, miR-128, and miR-29b, whereas non-responders demonstrated increased expression of miR-21, miR-155, miR-223, and miR-34a. Among individual miRNAs, miR-128 (AUC = 0.77) and miR-146a (AUC = 0.75) showed the strongest discriminatory performance. Pharmacoresistant TLE is associated with a distinct pattern of neuroinflammatory miRNA dysregulation and altered correlation network organization. Collectively, these findings support the concept that peripheral neuroimmune alterations are associated with pharmacoresistance and identify PBMC-derived neuroinflammatory miRNAs as promising candidate biomarker signatures supporting further validation in larger, independent cohorts with prospective study design.